Cipher Pharmaceuticals Inc. (TSX:CPH) is looking for acquisitions. Craig Mull, Interim Chief Executive Officer said, "As we look ahead, we continue to focus on enhancing long-term shareholder value and effectively allocating our capital. This involves a continued emphasis on investing in our commercial products to drive organic growth, advancing our development pipeline with our partners and assessing opportunities for profitable acquisitions".

Bryan Jacobs, Chief Financial Officer said, "We were highly successful in deploying the full allotment of capital of CAD 6 million, that we had targeted at onset of the offering. At these valuation levels, we believe this represented a highly attractive use of capital and an excellent lever to drive long-term shareholder value. At the end of the third quarter, we continue to have a very strong financial position with no debt and USD 42 million in cash, an increase of 46% from year-end 2022.

Combined with an undrawn USD 35 million revolving credit facility, we have substantial resources and financial flexibility to pursue acquisitions, and we continue to be very focused in this area".